Last viewed: BMRN

Prices are updated after-hours

BMRN Nasdaq

BioMarin Pharmaceutical Inc.

BMRN S | $88.68 -1.54% -1.57% 1.8M

|

Health Technology

(0.0% 1d) (7.5% 1m) (-5.9% 1y) (0.0% 2d) (0.0% 3d) (-0.5% 7d) (NaN% volume)
Earnings Calendar: 2024-02-22
Market Cap: $ 16,736,912,409
http://www.biomarin.com
Sec Filling | Patents | 3001 employees

(US) BioMarin Pharmaceutical, Inc. is a biotechnology company, which engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline include Vosoritide (BMN 111) for Achondroplasia and Valoctocogene Roxaparvovec (BMN 270) for Hemophilia A. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997 and is headquartered in San Rafael, CA.

Drugs

Brineura (cerliponase alfa)
Kuvan (sapropterin dihydrochloride)
Kuvan (SAPROPTERIN DIHYDROCHLORIDE)
NAGLAZYME (galsulfase)
Palynziq (pegvaliase-pqpz)
VIMIZIM (elosulfase alfa)

add to watch list Paper trade email alert is off

Press-releases

World Hemophilia Day 2024"Equitable access for all: recognizing all bleeding disorders"
Published: 2024-04-17 (Crawled : 04:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K

|

Health Technology

| 0.63% | O: 0.12% H: 0.51% C: 0.51%
SNY | News | $46.32 2.05% 2.01% 3.3M

|

Health Technology

| -0.78% | O: 1.05% H: 0.0% C: 0.0%
BMRN S | $88.68 -1.54% -1.57% 1.8M

|

Health Technology

| 0.26% | O: 0.26% H: 0.0% C: 0.0%
day bleeding world for

Biologic Therapeutics Market size is set to grow by USD 286.12 billion from 2023-2027, Introduction of biosimilars boost the market, Technavio
Published: 2024-04-15 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K

|

Health Technology

| -0.29% | O: -1.75% H: 0.85% C: 0.85%
AZNCF | $138.24 -4.19% 800

|

Health Technology

| -0.47% | O: 2.1% H: 0.0% C: -2.52%
NVS | $94.36 1.93% 0.0% 2.3M

|

Health Technology

| -1.19% | O: -1.46% H: 0.0% C: 0.0%
GSK | $39.75 1.22% 0.0% 1.6M

|

Health Technology

| -2.22% | O: -1.19% H: 0.52% C: -0.17%
BAX | $39.47 -0.45% 0.0% 2.8M

|

Health Technology

| -0.85% | O: -0.1% H: 0.13% C: -1.08%
ABBV | News | $166.41 1.06% 0.0% 5.5M

|

Health Technology

| 2.16% | O: 0.32% H: 0.96% C: 0.22%
SNY | News | $46.32 2.05% 2.01% 3.3M

|

Health Technology

| -2.9% | O: -2.13% H: 0.0% C: 0.0%
BMRN S | $88.68 -1.54% -1.57% 1.8M

|

Health Technology

| -0.46% | O: -0.72% H: 0.0% C: 0.0%
AZN | $68.56 0.29% 0.29% 4.7M

|

Health Technology

| -0.68% | O: -0.64% H: 0.45% C: -0.04%
AMGN | $269.03 2.39% 2.33% 3.4M

|

Health Technology

| -0.22% | O: 0.41% H: 0.0% C: 0.0%
set therapeutics market

BioMarin to Host First Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, April 24, 2024, at 4:30pm ET
Published: 2024-04-10 (Crawled : 13:00) - biospace.com/
BMRN S | $88.68 -1.54% -1.57% 1.8M

|

Health Technology

| 4.14% | O: 1.05% H: 2.3% C: 2.07%
first conference financial results

New Data to be Presented for BioMarin's VOXZOGO® (vosoritide) in Children with Hypochondroplasia and Achondroplasia at the American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting
Published: 2024-03-12 (Crawled : 12:30) - prnewswire.com
BMRN S | $88.68 -1.54% -1.57% 1.8M

|

Health Technology

| 5.92% | O: 0.31% H: 0.49% C: -1.26%
voxzogo children genomics achondroplasia meeting medical

BioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officer
Published: 2024-03-07 (Crawled : 13:30) - prnewswire.com
BMRN S | $88.68 -1.54% -1.57% 1.8M

|

Health Technology

| 4.98% | O: 0.51% H: 0.76% C: -1.51%
commercial

BioMarin Scheduled to Participate in March Investor Conferences
Published: 2024-03-01 (Crawled : 14:00) - prnewswire.com
BMRN S | $88.68 -1.54% -1.57% 1.8M

|

Health Technology

| 5.57% | O: 0.13% H: 2.18% C: 0.87%

BioMarin Reports Record Financial Results for the Fourth Quarter and Full-year 2023 and Provides Financial Guidance for 2024
Published: 2024-02-22 (Crawled : 21:00) - prnewswire.com
BMRN S | $88.68 -1.54% -1.57% 1.8M

|

Health Technology

| 1.24% | O: 1.08% H: 3.53% C: 0.33%
financial results

BioMarin to Host Fourth Quarter and Full-Year 2023 Financial Results Conference Call and Webcast on Thursday, February 22, 2024, at 4:30pm ET
Published: 2024-02-08 (Crawled : 13:00) - prnewswire.com
BMRN S | $88.68 -1.54% -1.57% 1.8M

|

Health Technology

| 1.59% | O: 0.12% H: 0.45% C: -1.8%
conference financial results

Biologic Therapeutics Market to Increase by USD 286.12 billion during 2022-2027, North America to account for 57% of the growth - Technavio
Published: 2024-02-07 (Crawled : 08:00) - prnewswire.com
AZNCF | $138.24 -4.19% 800

|

Health Technology

| 1.09% | O: -0.37% H: 0.0% C: 0.0%
NVSEF | $93.6375 6.88% 82K

|

Health Technology

| -8.98% | O: 0.41% H: 0.0% C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M

|

Health Technology

| -10.28% | O: 0.09% H: 0.39% C: -0.36%
GSK | $39.75 1.22% 0.0% 1.6M

|

Health Technology

| -5.15% | O: 0.43% H: 0.67% C: 0.21%
BAX | $39.47 -0.45% 0.0% 2.8M

|

Health Technology

| -0.03% | O: 0.21% H: 0.24% C: -1.04%
ABBV | News | $166.41 1.06% 0.0% 5.5M

|

Health Technology

| -3.43% | O: 1.48% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

|

Health Technology

| -2.19% | O: 1.33% H: 0.0% C: 0.0%
BMRN S | $88.68 -1.54% -1.57% 1.8M

|

Health Technology

| 1.44% | O: -0.38% H: 1.79% C: 0.22%
AZN | $68.56 0.29% 0.29% 4.7M

|

Health Technology

| 1.83% | O: -0.4% H: 0.19% C: -0.33%
AMGN | $269.03 2.39% 2.33% 3.4M

|

Health Technology

| -16.18% | O: -0.18% H: 0.0% C: -6.22%
america therapeutics growth market

BioMarin to Present ROCTAVIAN™ (valoctocogene roxaparvovec-rvox) Data Highlighting Long-Term Durability at 2024 European Association for Haemophilia and Allied Disorders (EAHAD) Congress
Published: 2024-02-06 (Crawled : 15:00) - biospace.com/
BMRN S | $88.68 -1.54% -1.57% 1.8M

|

Health Technology

| 3.84% | O: 0.46% H: 2.19% C: 1.91%
haemophilia congress association durability disorders

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001048477-24-000061	4	2024-04-12	2024-04-10	Sell	S	2286	16156

Your Today's Watch List

Sign in to create a watchlist

Gainers vs Losers

68%

32%

Top 10 Gainers

AGBA | News | $1.26 215.0% 68.25% 130M

|

EGOX | $0.0515 43.06% 30.1% 330M

|

OLB 4 | $0.33 -14.95% 25.53% 840K

|

Technology Services

NVFY | $2.77 31.28% 23.83% 33M

|

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M

|

Commercial Services

INSG | $3.03 25.21% 20.13% 330K

|

Electronic Technology

KNW 4 | $0.59 -0.71% 18.64% 27K

|

GCTK | $0.8191 22.25% 18.2% 190K

|

WLGS | News | $0.59 18.0% 17.9% 2.3M

|

ASNS | $0.828 21.75% 17.86% 18K

|

Last 48 Hours Insiders Buying

CLSD | $1.29 -2.27% -2.33% 230K

|

Health Technology

| 14:00
CDZI P 25000 | $2.25 0.0% 260K

|

| 14:00
ETST P 39000 | $0.068 -67.14% 43K

|

| 13:30
FNLC P 1275 | $22.97 3.66% 3.53% 21K

|

| 12:30
ADMQ | $0.0532 -40.18% 480K

|

| 10:30
AXR P 2400 | $21.0 -5.28% 0.0% 13K

|

| 21:00
QCRH P 118 | $57.315 3.44% 3.32% 66K

|

| 18:01
VUZI P 7500 | $1.19 -5.56% -5.88% 550K

|

Electronic Technology

| 18:00
RMCF | $3.67 3.38% 3.27% 11K

|

Consumer Non-Durables

| 20:10

12 months watchlist earnings calendar